Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety

Philippe Bouchard, Nathalie Chabbert-Buffet, Nathalie Chabbert‐Buffet, Bart C J M Fauser
Fertility and sterility · 2011 · vol. 96(5) , pp. 1175–1189 · doi:10.1016/j.fertnstert.2011.08.021 · PMID:21944187 · W2171626715
article OA: bronze CC0 ⤵ 31 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This review examines the pharmacology, clinical efficacy, and safety of selective progesterone receptor modulators (SPRMs) for applications in reproductive medicine.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715

MeSH descriptors

Hormone Antagonists Receptors, Progesterone Reproduction Abortifacient Agents Abortifacient Agents Abortion, Induced Animals Antineoplastic Agents, Hormonal Antineoplastic Agents, Hormonal Contraception, Postcoital Contraceptives, Postcoital Contraceptives, Postcoital Endometriosis Endometriosis Endometriosis Evidence-Based Medicine Female Hormone Antagonists Hormone Antagonists Humans

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Cited by (31)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:16:29.858026+00:00
License: CC0 · commercial use OK